Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Oseltamivir Phosphate Capsules

Approval Number

国药准字H20223173

Company广东东阳光药业股份有限公司

Registration Date

March 29, 2022

Drug Information

Generic Name

磷酸奥司他韦胶囊

Dosage Form

胶囊剂

Strength

75mg（以C16H28N2O4计）

Drug Type

化学药品

Registration Date

March 29, 2022

Company Information

Applicant Company

Company Name广东东阳光药业股份有限公司

Company Address

广东省东莞市松山湖园区工业北路1号

Manufacturing Company

Company Name广东东阳光药业股份有限公司

Company Address

广东省东莞市松山湖园区工业北路1号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy